Icrucumab
Product Specifications
CAS Number
1024603-92-6
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Purity
>95%
Bioactivity
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx001003-01 60 µL
Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody
Ask
View Details abx001003-02 120 µL
Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody
Ask
View Details abx001003-03 200 µL
Alkaline Phosphatase, Tissue-Nonspecific Isozyme (ALPL) Antibody
Ask
View Details 
MBS6378200-01 0.1 mL
FBP1 (Fructose-1,6-bisphosphatase 1, FBPase 1, D-fructose-1,6-bisphosphate 1-phosphohydrolase 1, FBP) (HRP)
Ask
View Details